Media

Support Of Industry Underscores Pro-Business Commitment
Washington, D.C. (September 22, 2014) – BIO President and CEO James Greenwood joined AdvaMed President and CEO Stephen Ubl and PhRMA President and CEO...

Press Releases

Dec 6 1999
(Carl Feldbaum, president of BIO, today issued the following statement upon the death of Bob Swanson, co-founder of Genentech): Washington, D.C. (December 6,...
Nov 24 1999
(Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement prior to the start of the World Trade Organization's...
Nov 23 1999
See Senate Resolution 200 below WASHINGTON, D.C. (Nov. 23, 1999) -- The Biotechnology Industry Organization (BIO) applauds the U.S. Senate for its adoption of...
Nov 22 1999
WASHINGTON, D.C. (Nov. 22, 1999) -- Included in the 2000 budget legislation passed by Congress are three measures that give a major boost to the biotechnology...
Nov 18 1999
The Biotechnology Industry Organization (BIO) is pleased to be invited by the Food and Drug Administration (FDA) to participate on the Food Safety Panel for...
Nov 18 1999
Thank you for inviting the Biotechnology Industry Organization (BIO) to provide a statement on the Food and Drug Administration's policy on information issues...
Nov 16 1999
WASHINGTON, D.C. (Nov. 16, 1999) -- The Biotechnology Industry Organization (BIO) fully concurs with the U.S. Food and Drug Administration's (FDA) initiative...
Nov 16 1999
WASHINGTON, D.C. -- (Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement in advance of the Food and Drug...
Nov 10 1999
(Michael J. Phillips, Ph.D, Executive Director for Food & Agriculture, issued the following statement in response to Congressman Kucinich's legislation...


Biotechnology News

October 21, 2014

PLEASANTON, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)--inVentiv Health Clinical, a leading global supplier of drug development services, will replace its electronic...

October 21, 2014

HYDERABAD, India--(BUSINESS WIRE)--GVK BIO Announces Successful Completion of Drug Repurposing Efforts to Identify Novel Indications

October 21, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (Nasdaq: KMDA) (TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces that a...

October 21, 2014

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced today that Dr. Anthony Lembo of Beth Israel Deaconess Medical Center will present the...

October 21, 2014

MODI’IN, Israel--(BUSINESS WIRE)--Exalenz Bioscience (TASE:EXEN), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range...